Novartis Plans Basel Lab Relocation, Potential 130 Swiss Job Cuts
Novartis AG may cut about 130 jobs in Switzerland as it relocates laboratory work to its main Basel campus and ends small-scale biologics production at the Kleinbasel site. Labs for biological cell banks, analytical testing and technical development are planned to move by end-2028, linked to expiring leases, with potential cuts subject to an information and consultation process.